The Psychedelic Renaissance—Hope or Hype?

In Partnership with The Retreat Farm's Wild Wisdom event series
Suggested Donation of $10
At the Retreat North Barn
Food and cash bar available

Join a panel of experts to explore the possibilities and realities of psilocybin and other plant medicines, from healing potential to their impact on Vermont’s economy. Curious about the neuroscience, therapeutic uses, legal issues, risks, or Indigenous perspectives? Come get your questions answered!

Panelists:

Katherine Maclean, PhD
At Johns Hopkins University School of Medicine, Katherine conducted legal clinical trials of psilocybin, the primary chemical found in "magic mushrooms”. She was a lead researcher and session guide on the first study to test the combined effects of high-dose psilocybin, daily meditation training and integration support. Katherine holds a BA in psychology and neuroscience from Dartmouth College, earned her PhD in research psychology with the University of California, Davis, and completed her postdoctoral research fellowship in psychopharmacology at the Johns Hopkins University School of Medicine.

Adriana Kertzer
Adriana holds a B.A. from Brown University in Judaic Studies and International Relations, a J.D. from the Georgetown University Law Center, and an M.A. from Parsons The New School for Design. Adriana was the principal of Plant Medicine Law Group, a law firm founded in 2020 that specialized in psychedelic infrastructure.

Justin Garner
Justin's academic background is in botany, plant chemistry, human physiology and biochemistry. He teaches about the nourishing, medicinal, and toxic properties of our diverse fungi.

Kurt White
Kurt is the VP of Community Partnerships, Communication, and Development at the Brattleboro Retreat. He earned his BA at the University of Chicago and his MSW at Smith College.